SEC Form 4 · accession 0000899243-17-015678
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Parkinson
Director
Period of report
Jun 5, 2017
Accepted (ET)
Jun 7, 2017 · 6:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.07 | Jun 5, 2017 | A | 50,000 | A | — | Jun 5, 2027 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The stock options will vest on the first to occur of (1) June 5, 2018, (2) immediately prior to the first annual meeting of the Company's shareholders that occurs in 2018 and at which one or more members of the Board are to be elected, or (3) immediately prior to the occurrence of a Change in Control (as such term is defined in the 2017 Equity Incentive Plan), subject to Dr. Parkinson's continued service through such date or event.